Raptamer Therapeutics
PrivateLast Round
Grant
Aug 11, 2021
Total Funding Raised
$3.72M
Company Overview
Raptamer Therapeutics operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Grant round in August 2021.
Raptamer Therapeutics is a biotechnology company that specializes in the development of next-generation, high-quality DNA molecules, called Raptamers, for use as therapeutic, diagnostic, or research agents.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Raptamer Therapeutics Comparables
Compare Raptamer Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Base Pair Biotechnologies | 86% | |
| Aptagen, LLC | 84% | |
| TAGCyx Biotechnologies Inc. | 83% |
For institutional investors. Book with your work email.
Raptamer Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 11, 2021 | ||||
| Grant | Jun 1, 2011 |
For institutional investors. Book with your work email.
Raptamer Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fannin Innovation Studio | M&A |
| Bill & Melinda Gates Foundation | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 11, 2021
$2M grant received from the National Institutes of Health.
- Jun 1, 2011
Received $1.7M from the Bill & Melinda Gates Foundation.
For institutional investors. Book with your work email.
Raptamer Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Raptamer Therapeutics's valuation, stock price, and market status.
Is Raptamer Therapeutics a public or private company?
Raptamer Therapeutics is a private company.
What is the current stock price of Raptamer Therapeutics?
Raptamer Therapeutics is a private company, so its shares have no public market price. Caplight tracks Raptamer Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Raptamer Therapeutics worth (valuation)?
Valuation information for Raptamer Therapeutics is not publicly available.
Can I buy Raptamer Therapeutics stock?
Raptamer Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Raptamer Therapeutics's last funding round?
Raptamer Therapeutics's most recent funding round was Grant on August 11, 2021.
Who are the main investors in Raptamer Therapeutics?
Key investors in Raptamer Therapeutics include Fannin Innovation Studio, Bill & Melinda Gates Foundation, National Institutes of Health (NIH).
Will Raptamer Therapeutics IPO soon?
No public IPO plans have been announced for Raptamer Therapeutics.
How can I track Raptamer Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Raptamer Therapeutics's shares on secondary markets.